Gainers

SINTX Technologies, Inc. SINT stock rose 235.14% to $2.59 during Monday's pre-market session.

Evoke Pharma, Inc. EVOK shares moved upwards by 80.43% to $4.24. The most recent rating by HC Wainwright & Co., on Jun 22, is at Buy, with a price target of $10.

FSD Pharma, Inc. HUGE shares increased by 28.67% to $5.43.

Evelo Biosciences, Inc. EVLO stock moved upwards by 27.18% to $4.75. The most recent rating by Morgan Stanley, on May 21, is at Equal-Weight, with a price target of $8.

Kitov Pharma, Inc. KTOV shares moved upwards by 18.73% to $0.68.

Miragen Therapeutics, Inc. MGEN stock moved upwards by 14.17% to $1.45.

VBI Vaccines, Inc. VBIV stock moved upwards by 13.84% to $3.29.

Cyclacel Pharmaceuticals, Inc. CYCC shares rose 10.91% to $4.98.

Agenus, Inc. AGEN stock increased by 10.44% to $4.23.

Sesen Bio, Inc. SESN shares increased by 9.91% to $0.80.

 

Losers

Nabriva Therapeutics, Inc. NBRV shares declined 15.25% to $0.70 during Monday's pre-market session. According to the most recent rating by H.C. Wainwright, on Apr 9, the current rating is at Neutral.

Biolase, Inc. BIOL stock declined 6.57% to $0.46.

Intec Pharma, Inc. NTEC stock fell 6.19% to $0.32.

Aethlon Medical, Inc. AEMD stock decreased by 5.66% to $2.50.

CytoSorbents, Inc. CTSO stock declined 4.54% to $8.62. The most recent rating by B. Riley FBR, on May 6, is at Buy, with a price target of $16.

Oncolytics Biotech, Inc. ONCY stock declined 3.55% to $1.90. The most recent rating by RBC Capital, on May 11, is at Outperform, with a price target of $6.

HEXO, Inc. HEXO shares fell 3.55% to $0.73. The most recent rating by Roth Capital, on Mar 31, is at Neutral, with a price target of $1.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!